Exhibit 32.1
CERTIFICATION
Pursuant to the requirement set forth in Rule 13a-14(b) of the Securities Exchange Act of 1934, as amended, (the “Exchange Act”) and Section 1350 of Chapter 63 of Title 18 of the United States Code (18 U.S.C. §1350), Barry Quart, Pharm.D., Chief Executive Officer of Heron Therapeutics, Inc. (the “Company”), and Lisa Peraza, Vice President, Chief Accounting Officer of the Company, each hereby certifies that, to the best of his or her knowledge:
Dated: March 29, 2023
In Witness Whereof, the undersigned have set their hands hereto as of the 29th day of March, 2023.
/s/ Barry Quart |
Barry Quart, Pharm.D. |
Chief Executive Officer |
(As Principal Executive Officer) |
|
/s/ Lisa Peraza |
Lisa Peraza |
Vice President, Chief Accounting Officer |
(As Principal Financial and Accounting Officer) |
This certification accompanies the Form 10-K to which it relates, is not deemed filed with the Securities and Exchange Commission and is not to be incorporated by reference into any filing of Heron Therapeutics, Inc. under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended (whether made before or after the date of the Form 10-K), irrespective of any general incorporation language contained in such filing.